Tumor cells lacking SERPINB5 expression tend to have lymph node metastasis and invasive progression of OSCC, and patients with high levels of SERPINB5 gene expression have better survival rates than those with low expression levels of SERPINB5 [1, 2, 4]. This evidence concerns the gene SERPINB5 and metastatic malignant neoplasm in the lymph nodes.